Logo1


Ivashchenko DV, Rudik AV, Poloznikov AA, Nikulin SV, Smirnov VV, Tonevitsky AG, Bryun EA, Sychev DA. Which cytochrome P450 metabolizes phenazepam? Step by step in silico, in vitro, and in vivo studies. Drug Metab Pers Ther. 2018 May 4.


doi: 10.1515/dmpt-2017-0036.

скачать материал

 

Kryukov AV, Sychev DA, Andreev DA, Ryzhikova KA, Grishina EA, Ryabova AV, Loskutnikov MA, Smirnov VV, Konova OD, Matsneva IA, Bochkov PO. Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. Pharmacogenomics and Personalized Medicine. 018,11:43—49.

DOI https://doi.org/10.2147/PGPM.S157111

скачать материал

 

 

Zastrozhin MS, Grishina EA, Ryzhikova KA, Smirnov VV, Savchenko LM, Bryun EA, Sychev DA. The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction. Pharmacogenomics and Personalized Medicine 2018,11:1—5.

DOI: https://doi.org/10.2147/PGPM.S144503

скачать материал

Sychev DA, Vardanyan A, Rozhkov A, Hachatryan E, Badanyan A, Smirnov V, Ananichuk A, Denisenko N. CYP3A Activity and Rivaroxaban Serum Concentrations in Russian Patients with Deep Vein Thrombosis. Genet Test Mol Biomarkers. 2018 Jan;22(1):51-54.
doi: 10.1089/gtmb.2017.0152.

скачать материал

Mirzaev KB, Sychev DA, Ryzhikova KA, Konova OD, Mammaev SN, Gafurov DM, Shuev GN, Grishina EA, Sozaeva ZA. Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan. Genetic testing and molecular biomarkers. 2017,12:1-7

DOI: 10.1089/gtmb.2017.0036

 

скачать материал